Chromatin modifying enzyme modulator (CTxONE/Pfizer/Cancer Therapeutics CRC)

N/A

Report date: 2025/03/14 16:38:04
NME

Base Information

Drug NameChromatin modifying enzyme modulator (CTxONE/Pfizer/Cancer Therapeutics CRC)
Drug Alias NameSmall molecule therapeutic (Cancer Therapeutics CRC/CTxONE/Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes modulators
TargetsEnzymes
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancer Therapeutics CRC Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCancer Therapeutics CRC Pty LtdPfizer Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A